Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Do elevated urinary D-arabinitol and citramalic acid reflect yeast or bacterial overgrowth and reduced nutrient availability?

Elevated urinary D-arabinitol is a strong marker of yeast overgrowth, citramalic acid may reflect microbial overgrowth, and dysbiosis can reduce nutrient availability.

PlausibleJuly 31, 202619 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Elevated urinary D-arabinitol and citramalic acid can reflect yeast or bacterial overgrowth, and dysbiosis can reduce nutrient availability by microbial competition and altered intestinal handling.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links urinary organic acids to microbial overgrowth in the gut. D-arabinitol is framed as a validated indicator of yeast activity, while citramalic acid is presented as a more tentative marker of bacterial or other dysbiosis-related activity. The mechanism also describes how dysbiosis can lower nutrient availability through microbial competition and impaired intestinal handling.

Verified conclusion

The assessment of urinary organic acids provides a non-invasive window into the gut microbiome, highlighting how microbial overgrowth alters host physiology and nutritional status in older adults.

Biomarkers of microbial overgrowth

  • Urinary D-arabinitol (DA): This five-carbon sugar alcohol is a metabolic byproduct of pathogenic Candida species like C. albicans. Because humans primarily produce L-arabinitol, the urinary DA/LA ratio is a highly sensitive and specific biomarker for fungal proliferation, successfully isolating yeast activity from host metabolism.
  • Urinary citramalic acid: Produced via the microbial citramalate synthase (CimA) pathway in yeasts (such as Saccharomyces) and anaerobic bacteria (like Clostridia), this dicarboxylic acid is a plausible marker of dysbiosis. However, it lacks clinical validation for diagnosing small intestinal bacterial overgrowth (SIBO) and is easily confounded by dietary fruit intake, such as apples.

Nutritional impact of dysbiosis

  • Direct microbial competition: Overgrowth of intestinal bacteria directly deprives the host of nutrients. Pathogens competitively consume dietary carbohydrates, proteins, and micronutrients—most notably vitamin B12 (cobalamin)—leading to host deficiencies despite adequate dietary intake.
  • Altered intestinal handling: Luminal bacteria deconjugate bile acids, impairing micellar fat solubilization and causing malabsorption of fats and fat-soluble vitamins (A, D, E, and K). Bacterial toxins and metabolites trigger mucosal inflammation, apical tight junction disruption, and villous atrophy, which reduces absorptive surface area and impairs brush-border disaccharidases.

Bottom line

  • Elevated urinary D-arabinitol is a robust, validated indicator of Candida overgrowth, whereas citramalic acid is a plausible but unvalidated marker of anaerobic microbial activity subject to dietary confounding. When dysbiosis is present, it directly compromises host nutrition through bacterial nutrient theft and structural damage to the absorptive intestinal barrier.

References

  1. D-arabinitol--a marker for invasive candidiasis — pubmed.ncbi.nlm.nih.gov ↗
  2. [PDF] D-arabinitol in the diagnosis of invasive candidiasis - LUCRIS — lucris.lub.lu.se ↗
  3. Arabinitol: Why It Is More Reliable Than Arabinose for ... — diagnosticsolutionslab.com ↗
  4. Arabinitol - Knowledge and References | Taylor & Francis — taylorandfrancis.com ↗
  5. Development and application of a rapid diagnostic method for invasive Candidiasis by the detection of D-/L-arabinitol using gas chromatography/mass spectrometry - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  6. JOURNAL OF CLINICAL MICROBIOLOGY, — pmc.ncbi.nlm.nih.gov ↗
  7. Urinary d-Arabinitol/l-Arabinitol Levels in Infants Undergoing ... — pmc.ncbi.nlm.nih.gov ↗
  8. ISSN 2321-807X — journals.indexcopernicus.com ↗
  9. Citramalic Acid Test — instalab.com ↗
  10. Citramalic - Organic Acids Test (OAT) — healthmatters.io ↗
  11. Citramalic Acid - Metabolic Analysis Markers (Urine) | Healthmatters.iohealthmatters.io › understand-blood-test-results › citramalic-acid — healthmatters.io ↗
  12. Small Intestinal Bacterial Overgrowth: A Comprehensive Review — pmc.ncbi.nlm.nih.gov ↗
  13. Bacterial Overgrowth Syndrome: Background, Pathophysiology, Epidemiology — emedicine.medscape.com ↗
  14. SIBO: Small Intestinal Bacterial Overgrowth — my.clevelandclinic.org ↗
  15. Small and Large Intestine (I): Malabsorption of Nutrients - PMC — pmc.ncbi.nlm.nih.gov ↗
  16. SIBO: Why You're Bloated, Gassy, and Not Absorbing Nutrients ... — ubiehealth.com ↗
  17. [PDF] Nutritional Consequences of Small Intestinal Bacterial Overgrowth — peirsoncenter.com ↗
  18. Increased Intestinal Permeability: An Avenue for the Development of Autoimmune Disease? — link.springer.com ↗
  19. Tight junctions: from molecules to gastrointestinal diseases — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→